Ads

 

Ads

 

Ads

 

Top Healthcare Companies in S&P 500 List by Market Cap as on July-30-2023

Top Healthcare Companies in S&P 500 List by Market Cap as on July-30-2023. Biggest and Top Healthcare Companies in S&P 500 Companies by Market Cap. Largest Top Healthcare Companies in S&P 500 List by Market Cap as on July-30-2023.
Metatag Title
Top Healthcare Companies in S&P 500
Metatag Abstract
Top Healthcare Companies in S&P 500, Biggest Healthcare Companies in S&P 500, Largest Healthcare Companies in S&P 500.
  1. Unitedhealth Group

    Market Cap (Mar-08-2026)
    260.03 Billion USD
    World Rank (Jan-05-2024)
    12
    Market Cap (Jan-05-2024)
    504.473 Billion USD
    World Rank (Jul-30-2023)
    12
    Market Cap (Jul-30-2023)
    468.230 Billion USD
    World Rank (Dec-25-2022)
    7
    Market Cap (Dec-25-2022)
    496.430 Billion USD
    World Rank (Jan-07-2022)
    16
    Market Cap (Jan-07-2022)
    431.93 Billion USD
    Annual Revenue in USD
    447,567 Million USD
    Annual Operating Income in USD
    18,964 Million USD
    Annual Net Income in USD
    12,056 Million USD
    Annual Results for Period Ending
    Dec-2025 ending year
    Headquarters Country
    Company Profile

    UnitedHealth Group is a health and well-being company headquartered in the United States, and helping people live healthier lives and helping make the health system work better. Headquarters is in USA.

    Facts About Company
    • UnitedHealth Group annual revenue generated for period ending Dec-2023 was 371.62 Billion USD.
    • UnitedHealth Group annual net income generated for period ending Dec-2023 was 22.38 Billion USD.
    • UnitedHealth Group annual revenue generated for period ending Dec-2022 was 322.13 Billion USD.
    • UnitedHealth Group annual net income generated for period ending Dec-2022 was 20.12 Billion USD.
    • UnitedHealth Group annual revenue generated for period ending Dec-2021 was 285.27 Billion USD.
    • UnitedHealth Group annual net income generated for period ending Dec-2021
  2. Johnson & Johnson

    Market Cap (Mar-08-2026)
    579.34 Billion USD
    World Rank (Jan-05-2024)
    21
    Market Cap (Jan-05-2024)
    387.499 Billion USD
    World Rank (Jul-30-2023)
    15
    Market Cap (Jul-30-2023)
    453.430 Billion USD
    World Rank (Dec-25-2022)
    8
    Market Cap (Dec-25-2022)
    464.020 Billion USD
    World Rank (Jan-07-2022)
    14
    Market Cap (Jan-07-2022)
    457.94 Billion USD
    Annual Revenue in USD
    94,193 Million USD
    Annual Operating Income in USD
    25,515 Million USD
    Annual Net Income in USD
    26,804 Million USD
    Annual Results for Period Ending
    Dec-2025 ending year
    Headquarters Country
    Company Profile

    Johnson & Johnson manufactures Consumer Goods, Medical Devices and Equipment and Pharmaceutical Products. As on 2023, Johnson & Johnson has 155,800 employees across 60 countries. Headquarters is in USA.

    As on December-2021, The Company’s subsidiaries operate 85 manufacturing facilities occupying approximately 15.0 million square feet of floor space for managing consumer goods, medical devices and pharmaceutical business segments.

    Facts About Company
    • Johnson & Johnson annual revenue generated for period ending Dec-2023 was 85.15 Billion USD and annual net income was 35.15 Billion USD
    • Johnson & Johnson annual revenue generated for period ending Dec-2022 was 94.94 Billion USD and annual net income was 17.94 Billion USD.
    • Johnson & Johnson annual revenue generated for period ending Dec-2021 was 93.77 Billion USD and annual net income was 20.87 Billion USD.

    Johnson & Johnson annual sales by segment wise for period ending in Dec-2022:

  3. Eli Lilly and Company

    Market Cap (Mar-08-2026)
    934.24 Billion USD
    World Rank (Jan-05-2024)
    10
    Market Cap (Jan-05-2024)
    586.387 Billion USD
    World Rank (Jul-30-2023)
    16
    Market Cap (Jul-30-2023)
    435.220 Billion USD
    World Rank (Dec-25-2022)
    19
    Market Cap (Dec-25-2022)
    349.570 Billion USD
    World Rank (Jan-07-2022)
    39
    Market Cap (Jan-07-2022)
    248.24 Billion USD
    Annual Revenue in USD
    65,179 Million USD
    Annual Operating Income in USD
    26,302 Million USD
    Annual Net Income in USD
    20,640 Million USD
    Annual Results for Period Ending
    Dec-2025 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Eli Lilly is a healthcare and pharmaceutical company and is USA based MNC company. Key business areas are Oncology, Bio-Medicines, Diabetes and also Animals Health. Headquarters is in USA.

    As of Jan-05-2024, Eli Lilly market cap was 586 Billion USD and it is World Top 10th rank company by market cap.

    As of August 2, 2026, Eli Lilly and Company had a market capitalization of approximately 1,029 billion USD, making it the world’s 14th-largest company by market capitalization.

    Facts About Company

    Eli Lilly Annual Revenue for the year ending December 2025 was 65,179 million USD, and Annual Net Income was 20,640 million USD.

    Eli Lilly Annual Revenue for the year ending December 2024 was 45,043 million USD, and Annual Net Income was 10,590 million USD.

    Eli Lilly Annual Revenue for the year ending December 2023 was 34,124 million USD, and Annual Net Income was 5,240 million USD.

    As of December 31, 2025, Eli Lilly had approximately 50,000 employees worldwide.

    As of December 31, 2024, Eli Lilly had approximately 47,000 employees worldwide.

  4. Merck & Co

    Market Cap (Mar-08-2026)
    286.28 Billion USD
    World Rank (Jan-05-2024)
    28
    Market Cap (Jan-05-2024)
    296.506 Billion USD
    World Rank (Jul-30-2023)
    32
    Market Cap (Jul-30-2023)
    269.830 Billion USD
    World Rank (Dec-25-2022)
    30
    Market Cap (Dec-25-2022)
    283.610 Billion USD
    World Rank (Jan-07-2022)
    59
    Market Cap (Jan-07-2022)
    202.83 Billion USD
    Annual Revenue in USD
    65,011 Million USD
    Annual Operating Income in USD
    21,218 Million USD
    Annual Net Income in USD
    18,254 Million USD
    Annual Results for Period Ending
    Dec-2025 ending year
    Headquarters Country
    Company Profile

    Merck & Co is USA based healthcare and pharmaceutical multi-national company. Merck Company manufacture and sells innovative medicines, vaccines, and animal health products. Headquarters is in USA.

    Merck & Co focus on scientific innovation to deliver medicines and vaccines.

    Facts About Company

    As on 2022, Merck & Co has 69,000 employees.

    For year ending Dec-2022, Merck & Co annual revenue was 59.28 billion USD and annual net income was 14.51 billion USD.

    For year ending Dec-2021, Merck & Co annual revenue was 48.70 million USD and annual net income was 13.04 million USD.

    Total Assets as on Dec-2022 was 109,160 Million USD.

  5. Abbvie

    Market Cap (Mar-08-2026)
    406.87 Billion USD
    World Rank (Jan-05-2024)
    32
    Market Cap (Jan-05-2024)
    285.064 Billion USD
    World Rank (Jul-30-2023)
    33
    Market Cap (Jul-30-2023)
    266.140 Billion USD
    World Rank (Dec-25-2022)
    29
    Market Cap (Dec-25-2022)
    288.440 Billion USD
    World Rank (Jan-07-2022)
    46
    Market Cap (Jan-07-2022)
    238.45 Billion USD
    Annual Revenue in USD
    61,160 Million USD
    Annual Operating Income in USD
    15,075 Million USD
    Annual Net Income in USD
    4,226 Million USD
    Annual Results for Period Ending
    Dec-2025 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Abbvie is USA based healthcare and pharmaceutical multi-national company. AbbVie is highly focus research-driven bio-pharmaceutical company. Headquarters is in USA.

    Facts About Company

    As on 2023, Abbvie has 50,000 employees.

    Abbvie annual revenue generated for period ending Dec-2022 was 58,054 million USD.

    Abbvie annual net income generated for period ending Dec-2022 was 11,782 million USD.

    Abbvie annual revenue generated for period ending Dec-2021 was 56,197 million USD.

    Abbvie annual net income generated for period ending Dec-2021 was 11,542 million USD.

    Total Assets as on Dec-2022 was 138,805 Million USD.

  6. Pfizer

    Market Cap (Mar-08-2026)
    153.81 Billion USD
    World Rank (Jan-05-2024)
    67
    Market Cap (Jan-05-2024)
    167.868 Billion USD
    World Rank (Jul-30-2023)
    53
    Market Cap (Jul-30-2023)
    203.630 Billion USD
    World Rank (Dec-25-2022)
    28
    Market Cap (Dec-25-2022)
    290.940 Billion USD
    World Rank (Jan-07-2022)
    27
    Market Cap (Jan-07-2022)
    312.75 Billion USD
    Annual Revenue in USD
    62,579 Million USD
    Annual Operating Income in USD
    7,520 Million USD
    Annual Net Income in USD
    7,771 Million USD
    Annual Results for Period Ending
    Dec-2025 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Pfizer is one of World's Top Pharmaceutical company and its headquarters is in New York, USA. Pfizer Products and Medicines are the results of 1500 scientists overseeing more than 500,000 lab tests and over 36 clinical trials before the first prescription. Pfizer develops medicines from simple diseases to most complex diseases in the world and their products are pharmaceutical drugs, vaccines.

    Facts About Company

    As of 2022, Pfizer has 83,000 employees.

    Pfizer annual revenue generated for period ending Dec-2022 was 100.33 billion USD.

    Pfizer annual net income generated for period ending Dec-2022 was 31.37 billion USD.

    As of 2021, Pfizer has 79,000 employees.

    Pfizer annual revenue generated for period ending Dec-2021 was 81.28 million USD.

    Pfizer annual net income generated for period ending Dec-2021 was 21.98 million USD.

  7. Abbott Laboratories

    Market Cap (Mar-08-2026)
    190.38 Billion USD
    World Rank (Jan-05-2024)
    57
    Market Cap (Jan-05-2024)
    192.668 Billion USD
    World Rank (Jul-30-2023)
    57
    Market Cap (Jul-30-2023)
    196.030 Billion USD
    World Rank (Dec-25-2022)
    51
    Market Cap (Dec-25-2022)
    188.620 Billion USD
    World Rank (Jan-07-2022)
    43
    Market Cap (Jan-07-2022)
    239.71 Billion USD
    Annual Revenue in USD
    44,328 Million USD
    Annual Operating Income in USD
    8,053 Million USD
    Annual Net Income in USD
    6,524 Million USD
    Annual Results for Period Ending
    Dec-2025 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Abbott Laboratories is USA based healthcare and pharmaceutical and is multi-national company. Abbott has presence in more than 150 countries. Key working areas of Abbott are related to Diabetes, Diagnostics, Neuro Modulation, Nutrition, Pharmaceuticals. They have over 113,000 employees as on 2021. Headquarters is in USA.

    Facts About Company

    As on 2022, Abbott Laboratories has 115,000 employees.

    Abbott Laboratories annual revenue generated for period ending Dec-2022 was 43,653 million USD.

    Abbott Laboratories annual net income generated for period ending Dec-2022 was 6,933 million USD.

    Abbott Laboratories annual revenue generated for period ending Dec-2021 was 43,075 million USD.

    Abbott Laboratories annual net income generated for period ending Dec-2021 was 7,071 million USD.

    Total Assets as on Dec-2021 was 75,196 Million USD.

  8. Danaher Corporation

    Market Cap (Mar-08-2026)
    138.25 Billion USD
    World Rank (Jan-05-2024)
    66
    Market Cap (Jan-05-2024)
    171.889 Billion USD
    World Rank (Jul-30-2023)
    58
    Market Cap (Jul-30-2023)
    192.020 Billion USD
    World Rank (Dec-25-2022)
    50
    Market Cap (Dec-25-2022)
    189.170 Billion USD
    World Rank (Jan-07-2022)
    58
    Market Cap (Jan-07-2022)
    211.28 Billion USD
    Annual Revenue in USD
    24,568 Million USD
    Annual Operating Income in USD
    4,690 Million USD
    Annual Net Income in USD
    3,614 Million USD
    Annual Results for Period Ending
    Dec-2025 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Danaher Corporation is USA based Science and Technology innovation company. They manufacture Consumer Products and Healthcare Products manufacturing, diagnostic, research and marketing company. They have around 78,000 employees as on December-2021. Headquarters is in USA.

    Below are the innovative technologies and companies making a difference related to Danaher Corporation:

    Facts About Company

    As on 2022, Danaher Corporation has 81,000 employees.

    Danaher Corporation annual revenue generated for period ending Dec-2022 was 31,471 million USD.

    Danaher Corporation annual net income generated for period ending Dec-2022 was 7,103 million USD.

    Danaher Corporation annual revenue generated for period ending Dec-2021 was 29,453 million USD.

    Danaher Corporation annual net income generated for period ending Dec-2021 was 7,465 million USD.

  9. Bristol-Myers Squibb Company

    Market Cap (Mar-08-2026)
    122.78 Billion USD
    World Rank (Jan-05-2024)
    130
    Market Cap (Jan-05-2024)
    106.418 Billion USD
    World Rank (Jul-30-2023)
    100
    Market Cap (Jul-30-2023)
    129.010 Billion USD
    World Rank (Dec-25-2022)
    66
    Market Cap (Dec-25-2022)
    154.980 Billion USD
    World Rank (Jan-07-2022)
    96
    Market Cap (Jan-07-2022)
    139.46 Billion USD
    Annual Revenue in USD
    48,194 Million USD
    Annual Operating Income in USD
    10,002 Million USD
    Annual Net Income in USD
    7,055 Million USD
    Annual Results for Period Ending
    Dec-2025 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Bristol-Myers Squibb is USA based healthcare and pharmaceutical multi-national company.

    BMS is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

    Company has over 32,200 employees as on 2021. Headquarters is in USA.

    BMS discover, develop and deliver innovative medicines that help patients prevail over serious diseases

    BMS be the biopharma company that transforms patients' lives through science.

    Facts About Company

    As on 2022, Bristol-Myers Squibb has 34,300 employees.

    Bristol-Myers Squibb annual revenue generated for period ending Dec-2022 was 46,159 million USD.

    Bristol-Myers Squibb annual net income generated for period ending Dec-2022 was 6,327 million USD.

    As on 2021, BMS had strong financial results with total revenues growing 9 percent year-over-year to $46.4 billion.

    Bristol-Myers Squibb annual revenue generated for period ending Dec-2021 was 46,385 million USD.

  10. Amgen

    Market Cap (Mar-08-2026)
    199.20 Billion USD
    World Rank (Jan-05-2024)
    73
    Market Cap (Jan-05-2024)
    162.250 Billion USD
    World Rank (Jul-30-2023)
    105
    Market Cap (Jul-30-2023)
    126.300 Billion USD
    World Rank (Dec-25-2022)
    80
    Market Cap (Dec-25-2022)
    140.820 Billion USD
    World Rank (Jan-07-2022)
    113
    Market Cap (Jan-07-2022)
    128.03 Billion USD
    Annual Revenue in USD
    36,751 Million USD
    Annual Operating Income in USD
    9,080 Million USD
    Annual Net Income in USD
    7,711 Million USD
    Annual Results for Period Ending
    Dec-2025 ending year
    Headquarters Country
    Company Profile

    Amgen main mission is to serve patients. Amgen is leader in Biotechnology industry, research and making Biotechnology Products. Company has over 25,200 employees as on 2022. Headquarters is in California, USA.

    Amgen Prevents Infections in Cancer Patients Program to Launch Innovative Tools to Improve Patient-Provider Conversations

    Amgen is dedicated to the fight against heart disease and has now launched Breakaway from Heart Disease™. The collective goal of this national campaign is to help make America’s heart health a priority.

    Facts About Company

    As on 2022, Amgen has 25,200 employees.

    Amgen annual revenue generated for period ending Dec-2022 was 26,323 million USD.

    Amgen annual net income generated for period ending Dec-2022 was 6,552 million USD.

    Amgen annual revenue generated for period ending Dec-2021 was 25,979 million USD.

    Split of Annual Revenue by business segment for period ending Dec-2021:

Share

Ads